MAPT and Cognitive impairment: Indeed, whilst it is becoming widely appreciated that multiple pathologies are the norm amongst dementia patients6, consensus criteria are still narrowly focused on identifying correlations between cognitive impairment and in vivo biomarkers of amyloid-β and tau accumulation7, with investigations into common co-pathologies given low priority at present.